Visit the Emergent Website
Heparinex | An Emergent Company


November 22, 2011
Heparinex, L.L.C. Awarded $1.6 Million EDGE Fund Endowment To Enable Chemistry, Manufacturing and Controls For Its Heparosan Proprietary Drug Delivery Technology    

February 3, 2009
Heparinex, L.L.C. Chief Scientist Dr. Paul DeAngelis Receives OCAST Research Funding Award    

January 25, 2007
Heparinex Chief Scientist Named OU College of Medicine Research Scholar    

Click here for Emergent Technologies news.

Visit related companies Emergent Technologies, Inc., Hyalose L.L.C. and
Pure Protein, L.L.C.

Copyright ©2009 Heparinex, L.L.C.. All rights reserved. Please read our Privacy Policy. Contact Us.